Allopurinol does not improve cardiovascular outcomes in ischaemic heart disease patients
Disappointing. Better data with colchicine
Related Articles
Neurological or Psychiatric Disorders After Dengue Fever
This cohort study investigates the association between dengue fever and risk of neurological and psychiatric disorders among adults in Taiwan.
Jim Simons, Math Genius Who Conquered Wall Street, Dies at 86
Using advanced computers, he went from M.I.T. professor to multibillionaire. His Medallion fund had 66 percent average annual returns for decades.
Study points to personalized treatment opportunities for glioblastoma
A study appearing in Cancer Cell uncovers the evolutionary dynamics of glioblastoma recurrence through proteogenomic analysis, offering potential therapeutic avenues.
How Do People Get Parasitic Brain Worms like the One RFK, Jr., Had?
Experts explain how certain worms can infect the brain and why they are an important global public health problem
Study: Anger could increase the risk of heart disease
Westwood One Radio asked Dr. Fahmi Farah, MD to come on the air for a live interview on 5/8/24 nationwide on ‘America at Night’ with…
Predicting MHC-I ligands across alleles and species: How far can we go?
CD8+ T-cell activation is initiated by the recognition of epitopes presented on class I major histocompatibility complex (MHC-I) molecules. Identifying such epitopes is useful for…
Exploring the Limits of EPR-driven Tumor Accumulation with Non-opsonizing Nanomaterials
The Enhanced Permeability and Retention (EPR) effect is a foundational concept used to rationalize nanomedicine development for cancer treatment and diagnostics. The attainable efficacy of…
Biden Administration to Pay Dairy Farmers for Bird Flu Protective Measures
The payment system amounted to one of the most forceful actions taken so far by agriculture officials who have raced to keep up with the…
Pulmonary Rehabilitation Utilization in Older Adults with Chronic Obstructive Pulmonary Disease, 2013–2019
Rationale: Pulmonary rehabilitation (PR) is very effective in patients with chronic obstructive pulmonary disease (COPD) for improving exercise tolerance and functional capacity, alleviating dyspne…
